Showing 41-50 out of 98
Page 5 of 10« First«...34567...10...»Last »
Sebetralstat, Investigational Oral On-Demand Treatment for HAE: KONFIDENT Trial DesignAygören-Pürsün E, Zanichelli A, Cohn DM, Farkas H, Bernstein JA, Audhya PK, Smith MD, Yea CM, Lumry WR, Riedl MA, Maurer M
IWAA 2023
Short-Term Prophylaxis With Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-SBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
IWAA 2023
In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack OnsetManning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
HAEA National Summit 2023
Recognizing the Importance of Early On-Demand Treatment in the HAE Attack JourneyJones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M
HAEA National Summit 2023
Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative StudyBukstein DA, Vibha Desai V, Goga L, Czado S, Brown M, Myers K, Audhya PK, Settipane RA, Busse PJ
HAEA National Summit 2023
PB0536: Oral Factor XIIa inhibitor KV998086 protects against FeCl3 induced thrombosis in mice.Clermont A, Pinckney F, Hill M, Hampton SL, Feener EP
ISTH 2023
Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacksGrumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T
EAACI 2023
Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxisBetschel S, van Kooten S, Heckmann M, Danese S, Caballero T
EAACI 2023
Short-Term Prophylaxis with Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-SBernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM
EAACI 2023
Results From a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial Evaluating Sebetralstat Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability in Healthy Japanese, Chinese, and White AdultsHide M, Iverson M, Jhee S, Hansen E, Duckworth EJ, Hampton SL, Yoon E, Honda D
EAACI 2023